Latest KFF Health News Stories
GAO To Launch Investigation Of FDA’s Orphan Drug Program
The Government Accountability Office said it will investigate potential abuses of the orphan drug program, which offers incentives to drugmakers to develop medicines for rare diseases.
I Do … Take You To Be My Lawfully Covered Health Care Dependent
They are in love. They also are worried about the uncertainty of the health law. So, they have a modest wedding during a blizzard so she can get his job-based insurance as soon as possible.
GOP Bill’s Unheralded Changes In Rules Could Undermine Health Of Neediest
Lesser-known provisions in the Republican proposal to replace the Affordable Care Act would push some Medicaid enrollees out of coverage and cause financial pain for others.
Prescription Drug Costs Are On The Rise; So Are The TV Ads Promoting Them
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
On Medicaid Money, GOP Has Win-Or-Lose Proposition For States
The House Republicans’ bill to repeal Obamacare would change how the federal government allocates matching funds to state Medicaid programs — and could cost some states billions of dollars a year in federal aid.
Researchers Call Trump’s Proposed NIH Cuts ‘Shocking’
Among the institutions that stand to lose most are those in California, especially the University of California and Stanford University.
Nueva droga baja el colesterol en forma drámatica y previene ataques, pero es costosísima
Por primera vez, una investigación muestra que un nuevo, y costoso, medicamento llamado Repatha no sólo baja dramáticamente los niveles de colesterol malo (LDL) sino que también reduce el riesgo de ser hospitalizado y de morir.
Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
$89,000 Orphan Drug Gets A New Owner — And Likely A New Price
Marathon, maker of an expensive treatment for Duchenne muscular dystrophy, sells the drug for $140 million in cash and stock to PTC Therapeutics.
Once Nearly Buried By Medical Bills, Farmer Braces For Insurance Drought
Barton County, Mo., is Trump country. And this rural area has big problems when it comes to health care. One farmer says he has a lot to lose under the Republican replacement plan.
Experimental Stem Cell Treatment Leaves Three Women Blind
Researchers, who detail the women’s experiences in the New England Journal of Medicine, say it exposes the need for better regulation of clinical trials.
Where You Live May Determine How You Die. Oregon Leads The Way.
A state with integrated systems for end-of-life care offers better treatment for the seriously ill, according to a new study.
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
Companies Behind Health Savings Accounts Could Bank On Big Profits Under GOP Plan
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
To Save On Drug Costs, Insurer Wants To Steer You To ‘Preferred’ Pharmacies
Blue Shield of California is hoping to steer consumers to “preferred” pharmacies where drugs are cheaper and copays lower.
Trump, Dems Look For Common Ground On Drug Prices
Two Democratic congressmen met with President Trump to seek his support for a bill to expand the government’s ability to negotiate drug prices, but it’s not clear it would have much impact or will gain support.
Proyecto republicano elimina el mandato individual y gran parte de la expansión del Medicaid
Los republicanos dieron a conocer el plan de salud con el que buscan reemplazar gran parte del Obamacare. Qué disposiciones se conservarían y cuáles podrían desaparecer por completo.
Three Key Senators Ask GAO To Investigate Possible Abuses Of The Orphan Drug Act
Amid an uproar over high drug prices, three GOP senators are asking the Government Accountability Office to investigate whether the Orphan Drug Act is being abused.
Are Virtual Doctor Visits Really Cost-Effective? Not So Much, Study Says
Rand Corp. finds that telehealth encourages patients to seek care for minor illnesses they wouldn’t bother to make an office visit for, raising overall health costs.
Cancer Rates Dropped During The Recession. That’s Not Necessarily A Good Thing.
Researchers believe Californians, many of whom lost health coverage, delayed doctor visits that could have led to earlier detection. Now, with people seeking medical care under the Affordable Care Act, some experts expect to see an increase in late-stage cancers.
